Exact Mass: 349.1381

Exact Mass Matches: 349.1381

Found 168 metabolites which its exact mass value is equals to given mass value 349.1381, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fentrazamide

4-(2-chlorophenyl)-N-cyclohexyl-N-ethyl-5-oxo-4,5-dihydro-1H-1,2,3,4-tetrazole-1-carboxamide

C16H20ClN5O2 (349.1305)


   
   
   

2-(Biaryl)carbapenems

2-(Biaryl)carbapenems

C21H19NO4 (349.1314)


   

Pefloxacin N-oxide

3-carboxy-1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinolin-1-ium-1-olate

C17H20FN3O4 (349.1438)


Pefloxacin N-oxide is a metabolite of pefloxacin. Pefloxacin is a synthetic chemotherapeutic agent used to treat severe and life threatening bacterial infections. Pefloxacin is commonly referred to as a fluoroquinolone drug and is a member of the fluoroquinolone class of antibacterials. It is an analog of norfloxacin. It is a synthetic fluoroquinolone, belonging to the 3rd generation of quinolones. Pefloxacin is extensively prescribed in France. Pefloxacin has not been approved for use in the United States. (Wikipedia) D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

   

5-[(3S)-1,2-Dithiolan-3-yl]pentanoylcarnitine

3-{[5-(1,2-dithiolan-3-yl)pentanoyl]oxy}-4-(trimethylazaniumyl)butanoic acid

C15H27NO4S2 (349.1381)


5-[(3S)-1,2-Dithiolan-3-yl]pentanoylcarnitine is an acylcarnitine. More specifically, it is an 5-[(3S)-1,2-dithiolan-3-yl]pentanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-[(3S)-1,2-Dithiolan-3-yl]pentanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-[(3S)-1,2-Dithiolan-3-yl]pentanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Bisnor-(+)-S-145

5-(3-{[hydroxy(phenyl)phosphoryl]amino}bicyclo[2.2.1]heptan-2-yl)pent-3-enoic acid

C18H24NO4P (349.1443)


   

Dihydrochelerythrine

17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1,3,8,10,12,14,16,18-octaene

C21H19NO4 (349.1314)


Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3]. Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3].

   

Emate

(13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl) sulfamate

C18H23NO4S (349.1348)


   

Glutathione monoisopropyl ester

2-amino-4-[(1-{[2-oxo-2-(propan-2-yloxy)ethyl]carbamoyl}-2-sulfanylethyl)carbamoyl]butanoic acid

C13H23N3O6S (349.1307)


   

Texaphyrin

13,20,25,26,27-pentaazapentacyclo[20.2.1.1^{3,6}.1^{8,11}.0^{14,19}]heptacosa-1,3,5,7,9,11(26),12,14,16,18,20,22(25),23-tridecaene

C22H15N5 (349.1327)


   

Dihydrochelerythrine

1,2-Dimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine

C21H19NO4 (349.1314)


Dihydrochelerythrine is a benzophenanthridine alkaloid. Dihydrochelerythrine is a natural product found in Zanthoxylum coriaceum, Zanthoxylum gilletii, and other organisms with data available. Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3]. Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3].

   

Dihydronitidine

(1,3)Benzodioxolo(5,6-c)phenanthridine, 12,13-dihydro-2,3-dimethoxy-12-methyl-

C21H19NO4 (349.1314)


   
   
   
   
   

Cyclo(-L-Trp-L-Tyr)

Cyclo(-L-Trp-L-Tyr)

C20H19N3O3 (349.1426)


   

tryptophan cis-4-aminocinnamamide

tryptophan cis-4-aminocinnamamide

C20H19N3O3 (349.1426)


   

(+)-(6aR,7R,E)-N-(but-2-enoyl)norushinsunine

(+)-(6aR,7R,E)-N-(but-2-enoyl)norushinsunine

C21H19NO4 (349.1314)


   

Buxifoliadine G

Buxifoliadine G

C21H19NO4 (349.1314)


   

Ochotensidine

Ochotensidine

C21H19NO4 (349.1314)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Oxarbazole

Oxarbazole

C21H19NO4 (349.1314)


C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent

   
   

Copper bis(2-ethylhexanoate)

Copper bis(2-ethylhexanoate)

C16H30CuO4 (349.144)


   
   

CP-466722

1-(6,7-dimethoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine

C17H15N7O2 (349.1287)


   

2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride

2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride

C15H24ClNO6 (349.1292)


   

Fmoc-(S)-3-Amino-5-hexynoic acid

Fmoc-(S)-3-Amino-5-hexynoic acid

C21H19NO4 (349.1314)


   

Hexanoic acid,2-ethyl-, copper salt (2:1)

Hexanoic acid,2-ethyl-, copper salt (2:1)

C16H30CuO4 (349.144)


   

N-FMOC-GUVACINE

N-FMOC-GUVACINE

C21H19NO4 (349.1314)


   
   
   

1-BOC-4-(4-AMINOPHENYL)PIPERAZINE DIHYDROCHLORIDE

1-BOC-4-(4-AMINOPHENYL)PIPERAZINE DIHYDROCHLORIDE

C15H25Cl2N3O2 (349.1324)


   

(-)-(1s,4r)-n-fmoc-4-aminocyclopent-2-enecarboxylic acid

(-)-(1s,4r)-n-fmoc-4-aminocyclopent-2-enecarboxylic acid

C21H19NO4 (349.1314)


   

(3S,4R)-1-BENZYL-4-(4-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

(3S,4R)-1-BENZYL-4-(4-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

C19H18F3NO2 (349.129)


   

[R-(R*,S*)]-3-[(2-hydroxy-1-methyl-2-phenylethyl)amino]-3-methoxypropiophenone hydrochloride

[R-(R*,S*)]-3-[(2-hydroxy-1-methyl-2-phenylethyl)amino]-3-methoxypropiophenone hydrochloride

C19H24ClNO3 (349.1445)


   

fmoc-(r)-3-amino-5-hexynoic acid

fmoc-(r)-3-amino-5-hexynoic acid

C21H19NO4 (349.1314)


   

4-[Bis(4-methoxyphenyl)amino]benzoic acid

4-[Bis(4-methoxyphenyl)amino]benzoic acid

C21H19NO4 (349.1314)


   

3,8-Diamino-5-ethyl-6-phenylphenanthridinium chl

3,8-Diamino-5-ethyl-6-phenylphenanthridinium chl

C21H20ClN3 (349.1346)


   

triphenyl(trimethylsilylimino)-λ5-phosphane

triphenyl(trimethylsilylimino)-λ5-phosphane

C21H24NPSi (349.1416)


   

Cinmetacin

1H-Indole-3-aceticacid, 5-methoxy-2-methyl-1-(1-oxo-3-phenyl-2-propen-1-yl)-

C21H19NO4 (349.1314)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   

4-CYCLOHEXYL-5-(3,4,5-TRIMETHOXY-PHENYL)-4H-[1,2,4]TRIAZOLE-3-THIOL

4-CYCLOHEXYL-5-(3,4,5-TRIMETHOXY-PHENYL)-4H-[1,2,4]TRIAZOLE-3-THIOL

C17H23N3O3S (349.146)


   

(4-PIPERAZIN-1-YL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER DIHYDROCHLORIDE

(4-PIPERAZIN-1-YL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER DIHYDROCHLORIDE

C15H25Cl2N3O2 (349.1324)


   
   

copper(II) isooctanoate

copper(II) isooctanoate

C16H30CuO4 (349.144)


   

Z-ALA-BETA-NAPHTHYL ESTER

Z-ALA-BETA-NAPHTHYL ESTER

C21H19NO4 (349.1314)


   

(1S,3R)-1-(1,3-Benzodioxol-5-yl)-N-methyl-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxamide

(1S,3R)-1-(1,3-Benzodioxol-5-yl)-N-methyl-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxamide

C20H19N3O3 (349.1426)


   

(R)-N-Fmoc-2-(2-propynyl)alanine

(R)-N-Fmoc-2-(2-propynyl)alanine

C21H19NO4 (349.1314)


   

tert-butyl 4-(4-aMinophenyl)piperazine-1-carboxylate dihydrochloride

tert-butyl 4-(4-aMinophenyl)piperazine-1-carboxylate dihydrochloride

C15H25Cl2N3O2 (349.1324)


   

Z-3-(1-naphthyl)-L-alanine

Z-3-(1-naphthyl)-L-alanine

C21H19NO4 (349.1314)


   

(S)-N-FMoc-2-(2--propynyl)alanine

(S)-N-FMoc-2-(2--propynyl)alanine

C21H19NO4 (349.1314)


   

Beryllium bis[2-(2-pyridinyl)phenolate]

Beryllium bis[2-(2-pyridinyl)phenolate]

C22H16BeN2O2 (349.1334)


   

Fmoc-L-propargylalanine

Fmoc-L-propargylalanine

C21H19NO4 (349.1314)


   

Adenosine,2,3-O-(1-methylethylidene)-, 5-acetate

Adenosine,2,3-O-(1-methylethylidene)-, 5-acetate

C15H19N5O5 (349.1386)


   

Desethylene Gatifloxacin

Desethylene Gatifloxacin

C17H20FN3O4 (349.1438)


   

(4-fluorophenyl)(4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)methanol

(4-fluorophenyl)(4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)methanol

C19H16FN5O (349.1339)


   

Biphenamine hydrochloride

Biphenamine hydrochloride

C19H24ClNO3 (349.1445)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   
   

5-amino-2-(diethylamino)-N-(2-methoxyphenyl)benzenesulfonamide

5-amino-2-(diethylamino)-N-(2-methoxyphenyl)benzenesulfonamide

C17H23N3O3S (349.146)


   

6-(benzo[d][1,3]dioxol-5-yl)-N-((tetrahydrofuran-3-yl)methyl)quinazolin-4-amine

6-(benzo[d][1,3]dioxol-5-yl)-N-((tetrahydrofuran-3-yl)methyl)quinazolin-4-amine

C20H19N3O3 (349.1426)


   

N-(1,3-benzodioxol-5-yl)-2,3-diethyl-6-quinoxalinecarboxamide

N-(1,3-benzodioxol-5-yl)-2,3-diethyl-6-quinoxalinecarboxamide

C20H19N3O3 (349.1426)


   

2-phenoxy-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]acetamide

2-phenoxy-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]acetamide

C20H19N3O3 (349.1426)


   

4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide

4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide

C16H17F2N5O2 (349.135)


   

AIDS-106788

(1,3)Benzodioxolo(5,6-c)phenanthridine, 12,13-dihydro-1,2-dimethoxy-12-methyl-

C21H19NO4 (349.1314)


Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3]. Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3].

   

3,8,9-Trimethoxy-5-methylbenzo[c]phenanthridin-2-one

3,8,9-Trimethoxy-5-methylbenzo[c]phenanthridin-2-one

C21H19NO4 (349.1314)


   
   

5-[(3S)-1,2-Dithiolan-3-yl]pentanoylcarnitine

5-[(3S)-1,2-Dithiolan-3-yl]pentanoylcarnitine

C15H27NO4S2 (349.1381)


   

(E)-5-[3-[(hydroxy-oxido-phenylphosphaniumyl)amino]-2-bicyclo[2.2.1]heptanyl]pent-3-enoic acid

(E)-5-[3-[(hydroxy-oxido-phenylphosphaniumyl)amino]-2-bicyclo[2.2.1]heptanyl]pent-3-enoic acid

C18H24NO4P (349.1443)


   

{[(2,6-difluorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide

{[(2,6-difluorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide

C16H17F2N5O2 (349.135)


   

Tetrazolium violet(1+)

Tetrazolium violet(1+)

C23H17N4+ (349.1453)


   

6-(1,3-benzodioxol-5-yl)-N-(2-oxolanylmethyl)-4-quinazolinamine

6-(1,3-benzodioxol-5-yl)-N-(2-oxolanylmethyl)-4-quinazolinamine

C20H19N3O3 (349.1426)


   

2-Furanyl-[4-(4-tetrazolo[1,5-a]quinoxalinyl)-1-piperazinyl]methanone

2-Furanyl-[4-(4-tetrazolo[1,5-a]quinoxalinyl)-1-piperazinyl]methanone

C17H15N7O2 (349.1287)


   

2-(2-Methoxyphenyl)-5-[2-(4-methoxyphenyl)ethylamino]-4-oxazolecarbonitrile

2-(2-Methoxyphenyl)-5-[2-(4-methoxyphenyl)ethylamino]-4-oxazolecarbonitrile

C20H19N3O3 (349.1426)


   

N-(2-oxolanylmethyl)-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

N-(2-oxolanylmethyl)-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

C20H19N3O3 (349.1426)


   

2-[(2-methyl-2,3-dihydroindol-1-yl)methyl]-4-oxo-1H-quinazoline-7-carboxylic acid methyl ester

2-[(2-methyl-2,3-dihydroindol-1-yl)methyl]-4-oxo-1H-quinazoline-7-carboxylic acid methyl ester

C20H19N3O3 (349.1426)


   

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-(3,5-dimethyl-1-pyrazolyl)benzamide

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-(3,5-dimethyl-1-pyrazolyl)benzamide

C20H19N3O3 (349.1426)


   

N-[1-oxo-3-phenyl-1-(2-pyridinylmethylamino)propan-2-yl]-2-furancarboxamide

N-[1-oxo-3-phenyl-1-(2-pyridinylmethylamino)propan-2-yl]-2-furancarboxamide

C20H19N3O3 (349.1426)


   

6-[(2,5-Dimethylphenyl)methyl]-3-(4-fluorophenyl)-7-triazolo[4,5-d]pyrimidinone

6-[(2,5-Dimethylphenyl)methyl]-3-(4-fluorophenyl)-7-triazolo[4,5-d]pyrimidinone

C19H16FN5O (349.1339)


   

methyl (5E)-5-[(4-hydroxyphenyl)methylidene]-2-methyl-1-(4-methylphenyl)-4-oxopyrrole-3-carboxylate

methyl (5E)-5-[(4-hydroxyphenyl)methylidene]-2-methyl-1-(4-methylphenyl)-4-oxopyrrole-3-carboxylate

C21H19NO4 (349.1314)


   

(15R)-13-(Furan-2-ylmethyl)-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15R)-13-(Furan-2-ylmethyl)-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

C20H19N3O3 (349.1426)


   

6-(1,3-benzodioxol-5-yl)-N-[[(2S)-2-oxolanyl]methyl]-4-quinazolinamine

6-(1,3-benzodioxol-5-yl)-N-[[(2S)-2-oxolanyl]methyl]-4-quinazolinamine

C20H19N3O3 (349.1426)


   
   
   
   

(1S)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol;chloride

(1S)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol;chloride

C19H24ClNO3 (349.1445)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Pefloxacin N-oxide

Pefloxacin N-oxide

C17H20FN3O4 (349.1438)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

   

Oblongine chloride

Oblongine chloride

C19H24ClNO3 (349.1445)


   
   

CFMTI

CFMTI

C19H16FN5O (349.1339)


CFMTI inhibits L-glutamate-induced intracellular Ca2+ mobilization in CHO cells expressing human and rat mGluR1a, with IC50s of 2.6 and 2.3 nM, respectively[1].

   

1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]but-2-en-1-one

1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]but-2-en-1-one

C21H19NO4 (349.1314)


   

11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

C20H19N3O3 (349.1426)


   

3,8,9-trimethoxy-5-methylcyclohexa[c]phenanthridin-2-one

3,8,9-trimethoxy-5-methylcyclohexa[c]phenanthridin-2-one

C21H19NO4 (349.1314)


   

methyl 2-(methylamino)-5-[(3s)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]benzoate

methyl 2-(methylamino)-5-[(3s)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]benzoate

C20H19N3O3 (349.1426)


   

(2s)-2-{[(2e)-3-(4-aminophenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

(2s)-2-{[(2e)-3-(4-aminophenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C20H19N3O3 (349.1426)


   

17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

C21H19NO4 (349.1314)


   

2-{[3-(4-aminophenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

2-{[3-(4-aminophenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C20H19N3O3 (349.1426)


   

(2s)-2-{[(2z)-3-(4-aminophenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

(2s)-2-{[(2z)-3-(4-aminophenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C20H19N3O3 (349.1426)


   

3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

C20H19N3O3 (349.1426)


   

(2e)-1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]but-2-en-1-one

(2e)-1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]but-2-en-1-one

C21H19NO4 (349.1314)


   

methyl 2-(methylamino)-5-[(3r)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]benzoate

methyl 2-(methylamino)-5-[(3r)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]benzoate

C20H19N3O3 (349.1426)


   

(7s,8s)-11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

(7s,8s)-11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

C20H19N3O3 (349.1426)


   

5-(4-hydroxyphenyl)-1-methyl-3-[2-(methylamino)ethyl]-7h-pyrrolo[3,2-f]indole-4,8-dione

5-(4-hydroxyphenyl)-1-methyl-3-[2-(methylamino)ethyl]-7h-pyrrolo[3,2-f]indole-4,8-dione

C20H19N3O3 (349.1426)


   

2-imino-7-methoxy-4-(4-methoxyphenyl)-1-methyl-3h-naphtho[2,3-d]imidazol-6-ol

2-imino-7-methoxy-4-(4-methoxyphenyl)-1-methyl-3h-naphtho[2,3-d]imidazol-6-ol

C20H19N3O3 (349.1426)


   

(3s,6r)-3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

(3s,6r)-3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

C20H19N3O3 (349.1426)


   

ethyl 2-{[(3r)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]amino}benzoate

ethyl 2-{[(3r)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]amino}benzoate

C20H19N3O3 (349.1426)


   

(3s,6s)-3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

C20H19N3O3 (349.1426)


   

16,17-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaene

16,17-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaene

C21H19NO4 (349.1314)


   

6-methyl-6'-methylidene-2',7,8,8'-tetrahydro-2h-spiro[[1,3]dioxolo[4,5-g]isoquinoline-5,7'-indeno[4,5-d][1,3]dioxole]

6-methyl-6'-methylidene-2',7,8,8'-tetrahydro-2h-spiro[[1,3]dioxolo[4,5-g]isoquinoline-5,7'-indeno[4,5-d][1,3]dioxole]

C21H19NO4 (349.1314)